1-2 of 2
Stephan Braun
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

γ9δ2 T-cell (γ9δ2TC) activation with ICT01 and azacitidine-venetoclax (Aza-Ven) induces high rates of remission and overall survival in patients with newly diagnosed (ND) acute myeloid leukemia (AML): Results from the phase 1/2 study eviction

Free
Sylvain Garciaz, Pierre-Yves Dumas, Pierre Peterlin, Daniel Morillo, Jose Miguel Torregrosa Diaz, Matthew Ulrickson, Agustin Penedo, Aude De Gassart, Emmanuel Valentin, Maelle Mairesse, George Saad, Patrick Brune, Katrien Lemmens, Noemi Angelosanto, Daniel Olive, Stephan Braun, Naval Daver, Abhishek Maiti
Journal: Blood
Blood (2025) 146 (Supplement 1): 652.
https://doi.org/10.1182/blood-2025-652
Published: 2025
Journal Articles

ICT01, an Investigational γ9δ2 T Cell Activator, Added to Azacitidine-Venetoclax Achieves Frequent and Early Complete Remissions in Adults with AML Unfit for Intensive Induction Chemotherapy: Interim Results from the Ongoing Open-Label, Randomized Phase 1 Study Eviction

Free
Abhishek Maiti, Pierre Yves Dumas, Pierre Peterlin, Daniel Morillo, Jose Torregrosa, Paul B. Koller, Maelle Mairesse, Patrick Brune, Emmanuel Valenitn, Aude De Gassart, Katrien Lemmens, Daniel Olive, Naval Daver, Stephan Braun, Sylvain Garciaz
Journal: Blood
Blood (2024) 144 (Supplement 1): 2876.
https://doi.org/10.1182/blood-2024-193493
Published: 2024